CBS and Dravet syndrome: The results demonstrated a marked suppression of mitochondrial respiration in DS cells and revealed that pharmacological inhibition of CBS or its siRNA-mediated silencing improves mitochondrial Complex IV activity, cellular oxygen consumption and ATP generation (Fig. 11) [18].